David Altschuler
Président chez One To One Children's Fund
Profil
David Altschuler is the founder of National Leasing & Finance Co. which was founded in 1980.
He is currently the Chairman of One To One Children's Fund, Paediatric Aids Treatment For Africa, Tel-Aviv University, and Director of National Family & Parenting Institute.
His former positions include Non-Executive Director at Arrow Therapeutics Ltd.
and Galapagos Biotech Ltd., Director at New Israel Fund, and Treasurer at Marks & Spencer Group Plc.
Postes actifs de David Altschuler
| Sociétés | Poste | Début |
|---|---|---|
Tel-Aviv University
 Tel-Aviv University Other Consumer ServicesConsumer Services Tel-Aviv University operates as a university in Israel. Its faculties include arts, engineering, science, humanities, law, life science, management, medicine, and social science. The company was founded in 1956 and is headquartered in Ramat Aviv, Israel. | Directeur/Membre du Conseil | - |
| National Family & Parenting Institute | Directeur/Membre du Conseil | - |
| One To One Children's Fund | Président | - |
| Paediatric Aids Treatment For Africa | Président | - |
Anciens postes connus de David Altschuler
| Sociétés | Poste | Fin |
|---|---|---|
| National Leasing & Finance Co. | Corporate Officer/Principal | - |
| MARKS & SPENCER GROUP PLC | Treasurer | - |
Arrow Therapeutics Ltd.
 Arrow Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Arrow Therapeutics Ltd. operates as a pharmaceutical company that focuses on research and development of novel antiviral drugs. Its products include novel antibacterial, antiviral, antifungal and preclinical compounds. The company was founded in 1998 and is headquartered in Cambridge, the United Kingdom. | Directeur/Membre du Conseil | - |
New Israel Fund
 New Israel Fund Investment Trusts/Mutual FundsMiscellaneous New Israel Fund operates as a grant-making foundation. The British company was founded in 1979. The CEO is Adam Ognall. | Directeur/Membre du Conseil | - |
Galapagos Biotech Ltd.
 Galapagos Biotech Ltd. BiotechnologyHealth Technology Galapagos Biotech Ltd. operates as a drug discovery company which provides discovery technologies and services. Its technologies include Chemogenomics and Silico. The company was founded by Kenneth Leslie Powell and Janet Maureen Thornton in July 8, 1997 and is headquartered in Cambridge, the United Kingdom. | Directeur/Membre du Conseil | - |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| MARKS & SPENCER GROUP PLC | Retail Trade |
| Entreprise privées | 7 |
|---|---|
Arrow Therapeutics Ltd.
Arrow Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Arrow Therapeutics Ltd. operates as a pharmaceutical company that focuses on research and development of novel antiviral drugs. Its products include novel antibacterial, antiviral, antifungal and preclinical compounds. The company was founded in 1998 and is headquartered in Cambridge, the United Kingdom. | Health Technology |
Galapagos Biotech Ltd.
Galapagos Biotech Ltd. BiotechnologyHealth Technology Galapagos Biotech Ltd. operates as a drug discovery company which provides discovery technologies and services. Its technologies include Chemogenomics and Silico. The company was founded by Kenneth Leslie Powell and Janet Maureen Thornton in July 8, 1997 and is headquartered in Cambridge, the United Kingdom. | Health Technology |
New Israel Fund
New Israel Fund Investment Trusts/Mutual FundsMiscellaneous New Israel Fund operates as a grant-making foundation. The British company was founded in 1979. The CEO is Adam Ognall. | Miscellaneous |
| National Family & Parenting Institute | |
| National Leasing & Finance Co. | |
| One To One Children's Fund | |
| Paediatric Aids Treatment For Africa |
